Avapritinib, sold under the brand name Ayvakit among others, is a medication used for the treatment of tumors due to one specific rare mutation: it is specifically intended for adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) that harbor a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation. Avapritinib is a kinase inhibitor.<\/p>\n
For inquiries regarding availability, import process, or cost of AYVAKIT (avapritinib) :<\/strong> Note:<\/strong> NEWS \/ UPDATES<\/strong><\/p>\n India Pharma Network acts solely as a facilitator for AYVAKIT (avapritinib) access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice. All imports are:<\/p>\n The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.<\/p>\n","protected":false},"excerpt":{"rendered":" AYVAKIT is a kinase inhibitor indicated for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (GIST)<\/strong>\u00a0harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.<\/p>\n
\nIndia Pharma Network (IPN)<\/strong>\u00a0: Headquartered in\u00a0New Delhi<\/strong>, with branch offices in\u00a0Delhi, Gurugram, Mumbai, Bangalore, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur\u00a0<\/strong>and\u00a0Lucknow<\/strong>, IPN supports medicine imports across India on a\u00a0Named Patient Import Basis<\/strong>\u00a0and for\u00a0personal use only<\/strong>.\u00a0Mobile\/WhatsApp:<\/strong>\u00a0Mr. Tarun: +91 9891 296 838 | \u00a0Mr. Neeraj: +91 9811 747 774.\u00a0Email:<\/strong>\u00a0info@indianpharmanetwork.co.in<\/a><\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n\n
Compliance & Disclaimer<\/h5>\n
\n
AYVAKIT (avapritinib) \u2013 GIST therapy in India<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n AYVAKIT<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n avapritinib<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 Tablets: 25 mg, 50 mg, 100 mg, 200 mg and 300 mg<\/td>\n<\/tr>\n \n Manufacturer:<\/strong><\/td>\n Blueprint Medicines Corporation<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n